Sentence examples for major depression will from inspiring English sources

In fact it's predicted that major depression will be the second leading cause of disability in the world by 2020.

One in five people with major depression will make such an attempt; there are approximately sixteen non-lethal attempts for every lethal one.

Conclusion: Lowering the prevalence rate of major depression will require close attention to public health approaches to address the relationships between smoking, social isolation, poor health, mood and physical well-being.

By the year 2020, it has been estimated that major depression will be the second most important cause of disability worldwide.

As a natural phenomenon, mania without major depression will of course survive DSM-5 and ICD-11, but following its integration as a diagnosis into bipolar-I disorder (BP-I) in those manuals, BP-I will be more heterogeneous and, paradoxically, will include a unipolar disorder.

The relapse rates are high: More than half of those who suffer from one episode of major depression will relapse at least once in their lifetimes, and roughly 80percentt of those who have had two episodes will experience another recurrence.

The occurrence of major depression (yes/no) will be the dependent variable of multiple logistic regressions from a multilevel analysis that will discern three levels: patient, GP and health centre.

"So it would be wrong to assume that just because it failed in this study of major depression, it will work in minor depression," he said.

The number of young people in the U.S. with major depression who will not receive any treatment, according to the Mental Health America report.

If patients meet the criteria for major depression, they will be advised to contact their general practitioner for an appropriate referral.> If patients are eligible and have signed written informed consent, they will start with a baseline assessment (T0).

Given that the main outcome measure, PHQ-9, has cut off points related to DSM IV depression conditions (e.g., dysthymia, major depression), we will be able to evaluate loss of benefit and retention of effect within the treatment group based on clinically relevant features.